Articles From: Altera SDK for OpenCL Development Flow Delivers Prototypes in Minutes to La Jolla Pharmaceutical Company Added to the Russell Microcap Index


Altera and Its Board Partners Accelerate Development of High-performance Computing, Networking and SoC Applications SAN JOSE, Calif.
Sign-up for Altera SDK for OpenCL Development Flow Delivers Prototypes in Minutes investment picks
WILMINGTON, Del., June 30, 2014 (GLOBE NEWSWIRE) -- Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, announced today that a shareholder has filed a class action lawsuit against Integrys Energy Group, Inc. ("Integrys" or the "Company") (NYSE:TEG) seeking to challenge the Company's recently announced merger.
Sign-up for LAWSUIT ALERT: The Law Firm of Andrews & Springer LLC Announces That A Class Action Lawsuit Has Been Filed Against Integrys Energy Group Inc. -- TEG investment picks
Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that Argentina’s National Administration of Drugs, Food and Medical Technology (ANMAT) has approved Lemtrada TM (alemtuzumab) for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.
Sign-up for Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis investment picks
WILMINGTON, Del., June 30, 2014 (GLOBE NEWSWIRE) -- Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, announced today that a shareholder has filed a class action lawsuit against PLX Technology Inc. ("PLX" or the "Company") (Nasdaq:PLXT) seeking to challenge the Company's recently announced merger.
Sign-up for LAWSUIT ALERT: The Law Firm of Andrews & Springer LLC Announces That A Class Action Lawsuit Has Been Filed Against PLX Technology, Inc. -- PLXT investment picks
2014/6/30
Leiden, The Netherlands, June 30, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, today announced the appointment of Willem W.
Sign-up for Prosensa Strengthens its Management Team and Supervisory Board with Key Appointments investment picks
WIXOM, Mich., June 30, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI) , a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, today announced that the U.S. Food & Drug Administration (FDA) granted its request for a small business waiver of the Prescription Drug User Fee Act (PDUFA) fee for its New Drug Application (NDA) for Triferic.
Sign-up for Rockwell Medical Announces FDA Approves $2.2 Million Application Fee Refund for Triferic(TM) NDA investment picks
MERRIMACK, N.H., June 30, 2014 (GLOBE NEWSWIRE) -- GT Advanced Technologies Inc., (Nasdaq:GTAT) , today announced a realignment of its manufacturing, engineering and supply chain resources to optimize effectiveness across its increasingly diversified business portfolio.
Sign-up for GT Announces Realignment of Manufacturing, Engineering and Supply Chain Resources investment picks
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna ® (imilecleucel-T), a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced its addition to the Russell Microcap ® Index.
Sign-up for Opexa Therapeutics Joins Russell Microcap Index investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from a global, investigational Phase 3 study to evaluate the safety and efficacy of EMEND ® (aprepitant) in the prevention of chemotherapy-induced nausea and vomiting (CINV) in pediatric cancer patients, aged 6 months to 17 years.
Sign-up for Merck Announces Data from Investigational Phase 3 Study on EMEND® (aprepitant) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Undergoing Emetogenic Chemotherapy investment picks
2014/6/30
NEW YORK , June 30, 2014 /PRNewswire/ -- On June 16, 2014 , the Credit Suisse NASDAQ Gold FLOWS 103 Index and the Credit Suisse NASDAQ Silver FLOWS 106 Index (the "Indices") concluded the notional sale of options on GLD shares and SLV shares with July expiration.
Sign-up for Credit Suisse Announces Expected July Coupon Payments on its Gold Shares Covered Call ETN (ticker symbol "GLDI") and its Silver Shares Covered Call ETN (ticker symbol "SLVO") investment picks
2014/6/30
JOHANNESBURG , June 30, 2014 /PRNewswire/ - Atlatsa Resources Corporation ("Atlatsa" or the "Company") (TSX, NYSE MKT, JSE: ATL) refers shareholders to the announcement released on Friday, 30 May 2014 regarding the no change statement and notice of Annual General and Special Meeting.
Sign-up for Atlatsa Resources Corporation - Results of Annual General and Special General Meeting investment picks
University of Phoenix, a subsidiary of Apollo Education Group (Nasdaq: APOL), and AMVETS, a vocal advocate for veterans’ education, are still accepting applications to award 20 full-tuition scholarships to prospective students who are active-duty service members, eligible family members and veterans to pursue an undergraduate or master’s degree from University of Phoenix.
Sign-up for University of Phoenix and AMVETS Continue to Accept Applications for Scholarship Program investment picks
Alnylam Pharmaceuticals, Inc .
Sign-up for Alnylam Added to Russell 1000 Index as a Member of the Large-Cap Segment of the U.S. Equity Universe investment picks
- Positions TreeHouse as the private label leader in the on-trend and high growth healthy snacks sector - Increases annual revenue by approximately $750 million - Estimated EPS accretion of $0.24 - $0.28 in first full year following closing - TreeHouse expects to fund the transaction through a combination of borrowings under TreeHouse's existing credit facility and capital market financings OAKBROOK, Ill., June 30, 2014 /PRNewswire/ -- TreeHouse Foods, Inc. (NYSE: THS) today announced that it will acquire Flagstone Foods, the leading provider of private label healthy snacks, one of the fastest growing on-trend categories in the food industry.
Sign-up for TreeHouse Foods to Acquire Flagstone Foods for $860 million investment picks
SOUTH PLAINFIELD, N.J. , June 30, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it is the recipient of Parent Project Muscular Dystrophy's (PPMD) "Path to Progress" award, honoring PTC's 16 years of commitment to bring the first-ever therapy for the underlying cause of the disorder to patients with Duchenne muscular dystrophy (DMD). The award was presented at PPMD's Annual Connect Conference in Chicago, Illinois .
Sign-up for PTC Therapeutics Recipient of Parent Project Muscular Dystrophy's "Path to Progress" Award investment picks
SOUTH PLAINFIELD, N.J. , June 30, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the initiation of a global confirmatory Phase 3 clinical trial of Translarna™ (ataluren), an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF). Nonsense mutations within cystic fibrosis are categorized as Class I mutations, a severe form of CF that results in little or no production of the CFTR protein.
Sign-up for PTC Therapeutics Initiates Confirmatory Phase 3 Clinical Trial of Translarna™ (ataluren) in Patients with Nonsense Mutation Cystic Fibrosis (nmCF) investment picks
BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX) , a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the appointment of The Honorable Paul Jude Tonna to its Board of Directors.
Sign-up for BioRestorative Therapies Appoints The Honorable Paul Jude Tonna to its Board of Directors investment picks
2014/6/30
Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the second quarter of 2014 prior to its quarterly earnings call on Thursday, July 31, 2014, at 8:00 a.m. EDT.
Sign-up for Quintiles’ Second Quarter 2014 Earnings Call Scheduled for Thursday, July 31st investment picks
OSI Systems, Inc. (NASDAQ: OSIS), today announced that its Security division, Rapiscan Systems, has received an order for approximately $12 million from a U.S. government agency to perform on-going maintenance and support services on several Rapiscan inspection platforms including the Eagle® M60 mobile high energy X-ray cargo and vehicle inspection system and 620DV (Dual View) baggage and parcel inspection system.
Sign-up for OSI Systems Receives $12 Million Order to Provide Service and Maintenance Support for Inspection Systems investment picks
Campus Crest Communities, Inc. (the “Company”) (NYSE:CCG), today announced that the Company will release its second quarter 2014 financial results after the market close on Wednesday, July 30, 2014.
Sign-up for CCG Schedules Q2 2014 Earnings Release and Call investment picks
1347 Property Insurance Holdings, Inc. (NASDAQ:PIH) (“PIH” or “the Company”), a property and casualty insurance holding company offering homeowners’ and dwelling insurance, today announced that the Company has been selected to join the Russell Microcap® Index as part of Russell Investments reconstitution of its comprehensive set of U.S. and global equity indexes.
Sign-up for 1347 Property Insurance Holdings, Inc. to Join the Russell Microcap® Index investment picks
New Wocketwallet.com Ad; "Introducing Wocket, the Smart Wallet" SHELTON, Conn., June 30, 2014 /PRNewswire/ -- NXT-ID, Inc., (OTCQB: NXTD) (OTCBB: NXTD) a biometric authentication company focused on the growing m-commerce market, is pleased to announce that the second series of 30 second spots on CNBC for its next generation smart wallet, Wocket™, will begin the week of July 7th .
Sign-up for NXT-ID Resumes CNBC Ad Campaign for its Next Generation Smart Wallet, Wocket™; to Commence Week of July 7th investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced the presentation of preclinical data demonstrating the promise of DCR-PH1, the Company’s therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1), a rare inherited liver disorder that often results in progressive and severe kidney damage.
Sign-up for Researchers Demonstrate Promise of Dicerna Investigational Therapy in Preclinical Model of Primary Hyperoxaluria Type 1 (PH1) investment picks
Sitara™ AM437x processors, based on an ARM® Cortex®-A9 core, provides options for enhanced processing performance and industrial connectivity DALLAS , June 30, 2014 /PRNewswire/ -- Today, Texas Instruments (TI) (NASDAQ: TXN) announced the new Sitara™ AM437x processor family that integrates support for industrial protocols for both automation and industrial drives and includes new features such as dual camera for data terminals with bar code scanning.
Sign-up for Get the best of both worlds: New processor family brings higher performance with real-time processing investment picks
SciQuest, Inc. (NASDAQ: SQI), a leading provider of cloud-based business automation solutions for spend management, today announced that Quality Supply Chain Co-op, Inc. SM (QSCC), the independent, not-for-profit organization that oversees the supply chain for more than 6,100 Wendy’s ® restaurants in North America, has expanded its use of SciQuest’s Advanced Sourcing Optimizer (ASO). A SciQuest customer since 2011, QSCC now uses SciQuest’s ASO to automate the e-sourcing process for more than 30 percent of the company’s spend.
Sign-up for Quality Supply Chain Co-op Beefs Up E-Sourcing Strategy for Wendy’s with SciQuest investment picks
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced that the Company was added to the Russell Microcap Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indices on June 27.
Sign-up for La Jolla Pharmaceutical Company Added to the Russell Microcap Index investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Altera SDK for OpenCL Development Flow Delivers Prototypes in Minutes to La Jolla Pharmaceutical Company Added to the Russell Microcap Index
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices